In intensified bioprocessing, the engineered CHO host supports higher titers and long culture duration in continuous ...

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

Sartorius has launched a new genetically engineered CHO host cell line designed to improve productivity and efficiency.

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Peer-reviewed study demonstrates precision genome editing, stable integration, and high-producing CHO platforms for commercial biomanufacturingLEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra AgBio (Demeetra ...

“Partnering with Demeetra strengthens our ability to support biotech companies with a rapid and reliable path to GMP material ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority ...

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...